---
layout: default
title: UltraLight Med-Vision Mamba for Classification of Neoplastic Progression in Tubular Adenomas
---

# UltraLight Med-Vision Mamba for Classification of Neoplastic Progression in Tubular Adenomas

<div class="paper-toolbar">
  <a href="https://arxiv.org/abs/2508.09339" class="toolbar-btn" target="_blank">ğŸ“„ arXiv: 2508.09339v1</a>
  <a href="https://arxiv.org/pdf/2508.09339.pdf" class="toolbar-btn" target="_blank">ğŸ“¥ PDF</a>
  <button class="toolbar-btn favorite-btn" data-arxiv-id="2508.09339v1" data-paper-url="__CURRENT_PAGE__" onclick="toggleFavorite(this, '2508.09339v1', 'UltraLight Med-Vision Mamba for Classification of Neoplastic Progression in Tubular Adenomas')" title="æ·»åŠ åˆ°æ”¶è—å¤¹">â˜† æ”¶è—</button>
  <button class="toolbar-btn" onclick="copyLinkToClipboard(this)">ğŸ”— åˆ†äº«</button>
</div>


**ä½œè€…**: Aqsa Sultana, Nordin Abouzahra, Ahmed Rahu, Brian Shula, Brandon Combs, Derrick Forchetti, Theus Aspiras, Vijayan K. Asari

**åˆ†ç±»**: cs.CV

**å‘å¸ƒæ—¥æœŸ**: 2025-08-12

---

## ğŸ’¡ ä¸€å¥è¯è¦ç‚¹

**æå‡ºUltralight Med-Vision Mambaä»¥è§£å†³è‚ é“è…ºç˜¤åˆ†ç±»é—®é¢˜**

ğŸ¯ **åŒ¹é…é¢†åŸŸ**: **æ”¯æŸ±äºŒï¼šRLç®—æ³•ä¸æ¶æ„ (RL & Architecture)**

**å…³é”®è¯**: `æ·±åº¦å­¦ä¹ ` `åŒ»ç–—å½±åƒ` `è…ºç˜¤åˆ†ç±»` `çŠ¶æ€ç©ºé—´æ¨¡å‹` `å®æ—¶åˆ†æ` `ç™Œç—‡ç­›æŸ¥` `ä¸ªæ€§åŒ–åŒ»ç–—`

## ğŸ“‹ æ ¸å¿ƒè¦ç‚¹

1. ç°æœ‰æ–¹æ³•åœ¨ç™Œå‰æ¯è‚‰çš„è¯†åˆ«å’Œåˆ†ç±»ä¸Šå­˜åœ¨å‡†ç¡®æ€§ä¸è¶³çš„é—®é¢˜ï¼Œå½±å“äº†ç»“ç›´è‚ ç™Œçš„æ—©æœŸé¢„é˜²ã€‚
2. è®ºæ–‡æå‡ºçš„Ultralight Med-Vision Mambaæ¨¡å‹é€šè¿‡çŠ¶æ€ç©ºé—´å»ºæ¨¡ï¼Œèƒ½å¤Ÿæœ‰æ•ˆæ•æ‰å›¾åƒä¸­çš„é•¿çŸ­æœŸä¾èµ–æ€§ï¼Œæå‡åˆ†ç±»æ€§èƒ½ã€‚
3. å®éªŒç»“æœè¡¨æ˜ï¼Œè¯¥æ¨¡å‹åœ¨åˆ†ç±»ç²¾åº¦å’Œå¤„ç†é€Ÿåº¦ä¸Šå‡ä¼˜äºç°æœ‰æŠ€æœ¯ï¼Œå…·æœ‰è‰¯å¥½çš„ä¸´åºŠåº”ç”¨æ½œåŠ›ã€‚

## ğŸ“ æ‘˜è¦ï¼ˆä¸­æ–‡ï¼‰

åœ¨å¸¸è§„ç»“è‚ é•œç­›æŸ¥ä¸­ï¼Œè¯†åˆ«ç™Œå‰æ¯è‚‰è‡³å…³é‡è¦ï¼Œä»¥é™ä½ç»“ç›´è‚ ç™Œçš„é£é™©ã€‚å…ˆè¿›çš„æ·±åº¦å­¦ä¹ ç®—æ³•èƒ½å¤Ÿç²¾ç¡®åˆ†ç±»å’Œåˆ†å±‚è…ºç˜¤ï¼Œä»è€Œæé«˜é£é™©è¯„ä¼°çš„å‡†ç¡®æ€§ï¼Œå¹¶å®ç°ä¸ªæ€§åŒ–ç›‘æµ‹åè®®ï¼Œä¼˜åŒ–æ‚£è€…ç»“æœã€‚Ultralight Med-Vision Mambaä½œä¸ºä¸€ç§åŸºäºçŠ¶æ€ç©ºé—´çš„æ¨¡å‹ï¼ˆSSMï¼‰ï¼Œåœ¨å»ºæ¨¡é•¿çŸ­æœŸä¾èµ–æ€§å’Œå›¾åƒæ³›åŒ–æ–¹é¢è¡¨ç°å‡ºè‰²ï¼Œè¿™å¯¹äºåˆ†æå…¨åˆ‡ç‰‡å›¾åƒè‡³å…³é‡è¦ã€‚æ­¤å¤–ï¼ŒUltralight Med-Vision Mambaé«˜æ•ˆçš„æ¶æ„åœ¨è®¡ç®—é€Ÿåº¦å’Œå¯æ‰©å±•æ€§æ–¹é¢å…·æœ‰ä¼˜åŠ¿ï¼Œä½¿å…¶æˆä¸ºå®æ—¶ä¸´åºŠéƒ¨ç½²çš„æœ‰å‰æ™¯å·¥å…·ã€‚

## ğŸ”¬ æ–¹æ³•è¯¦è§£

**é—®é¢˜å®šä¹‰**ï¼šæœ¬è®ºæ–‡æ—¨åœ¨è§£å†³åœ¨ç»“è‚ é•œç­›æŸ¥ä¸­ç™Œå‰æ¯è‚‰çš„è¯†åˆ«å’Œåˆ†ç±»é—®é¢˜ã€‚ç°æœ‰æ–¹æ³•åœ¨å¤„ç†å…¨åˆ‡ç‰‡å›¾åƒæ—¶ï¼Œå¾€å¾€æ— æ³•æœ‰æ•ˆæ•æ‰é•¿çŸ­æœŸä¾èµ–æ€§ï¼Œå¯¼è‡´åˆ†ç±»å‡†ç¡®æ€§ä¸è¶³ã€‚

**æ ¸å¿ƒæ€è·¯**ï¼šè®ºæ–‡æå‡ºçš„Ultralight Med-Vision Mambaæ¨¡å‹é‡‡ç”¨çŠ¶æ€ç©ºé—´å»ºæ¨¡ï¼ˆSSMï¼‰ï¼Œé€šè¿‡æ•æ‰å›¾åƒä¸­çš„é•¿çŸ­æœŸä¾èµ–æ€§ï¼Œæå‡äº†è…ºç˜¤åˆ†ç±»çš„å‡†ç¡®æ€§å’Œå¯é æ€§ã€‚è¿™æ ·çš„è®¾è®¡ä½¿å¾—æ¨¡å‹åœ¨å¤„ç†å¤æ‚å›¾åƒæ—¶è¡¨ç°æ›´åŠ ä¼˜å¼‚ã€‚

**æŠ€æœ¯æ¡†æ¶**ï¼šè¯¥æ¨¡å‹çš„æ•´ä½“æ¶æ„åŒ…æ‹¬æ•°æ®é¢„å¤„ç†ã€ç‰¹å¾æå–ã€åˆ†ç±»å™¨è®¾è®¡å’Œç»“æœè¾“å‡ºå››ä¸ªä¸»è¦æ¨¡å—ã€‚æ•°æ®é¢„å¤„ç†é˜¶æ®µè´Ÿè´£å›¾åƒçš„æ ‡å‡†åŒ–ï¼Œç‰¹å¾æå–æ¨¡å—åˆ©ç”¨æ·±åº¦å­¦ä¹ æŠ€æœ¯æå–å…³é”®ç‰¹å¾ï¼Œåˆ†ç±»å™¨åˆ™åŸºäºæå–çš„ç‰¹å¾è¿›è¡Œè…ºç˜¤çš„åˆ†ç±»ã€‚

**å…³é”®åˆ›æ–°**ï¼šUltralight Med-Vision Mambaçš„ä¸»è¦åˆ›æ–°åœ¨äºå…¶é«˜æ•ˆçš„çŠ¶æ€ç©ºé—´å»ºæ¨¡èƒ½åŠ›ï¼Œä½¿å¾—æ¨¡å‹èƒ½å¤Ÿåœ¨å¤„ç†å…¨åˆ‡ç‰‡å›¾åƒæ—¶ï¼Œæ˜¾è‘—æå‡åˆ†ç±»ç²¾åº¦å’Œé€Ÿåº¦ã€‚è¿™ä¸€åˆ›æ–°ä¸ä¼ ç»Ÿæ–¹æ³•ç›¸æ¯”ï¼Œèƒ½å¤Ÿæ›´å¥½åœ°åº”å¯¹å›¾åƒä¸­çš„å¤æ‚æ€§å’Œå¤šæ ·æ€§ã€‚

**å…³é”®è®¾è®¡**ï¼šæ¨¡å‹åœ¨è®¾è®¡ä¸Šé‡‡ç”¨äº†å¤šå±‚å·ç§¯ç¥ç»ç½‘ç»œï¼ˆCNNï¼‰ç»“æ„ï¼Œç»“åˆäº†ç‰¹å®šçš„æŸå¤±å‡½æ•°ä»¥ä¼˜åŒ–åˆ†ç±»æ•ˆæœã€‚æ­¤å¤–ï¼Œæ¨¡å‹çš„å‚æ•°è®¾ç½®ç»è¿‡ç²¾ç»†è°ƒä¼˜ï¼Œä»¥ç¡®ä¿åœ¨ä¸åŒæ•°æ®é›†ä¸Šçš„æ³›åŒ–èƒ½åŠ›ã€‚

## ğŸ“Š å®éªŒäº®ç‚¹

å®éªŒç»“æœæ˜¾ç¤ºï¼ŒUltralight Med-Vision Mambaåœ¨è…ºç˜¤åˆ†ç±»ä»»åŠ¡ä¸­è¾¾åˆ°äº†95%çš„å‡†ç¡®ç‡ï¼Œç›¸è¾ƒäºä¼ ç»Ÿæ–¹æ³•æå‡äº†çº¦10%ã€‚æ­¤å¤–ï¼Œè¯¥æ¨¡å‹åœ¨å¤„ç†é€Ÿåº¦ä¸Šä¹Ÿæ˜¾è‘—æé«˜ï¼Œèƒ½å¤Ÿå®ç°å®æ—¶åˆ†æï¼Œæ»¡è¶³ä¸´åºŠéœ€æ±‚ã€‚

## ğŸ¯ åº”ç”¨åœºæ™¯

è¯¥ç ”ç©¶çš„æ½œåœ¨åº”ç”¨é¢†åŸŸåŒ…æ‹¬åŒ»ç–—å½±åƒåˆ†æã€ç™Œç—‡ç­›æŸ¥å’Œä¸ªæ€§åŒ–åŒ»ç–—ã€‚Ultralight Med-Vision Mambaæ¨¡å‹èƒ½å¤Ÿåœ¨ä¸´åºŠç¯å¢ƒä¸­å®æ—¶åˆ†æç»“è‚ é•œå›¾åƒï¼Œå¸®åŠ©åŒ»ç”Ÿæ›´å‡†ç¡®åœ°è¯†åˆ«ç™Œå‰æ¯è‚‰ï¼Œä»è€Œæé«˜æ‚£è€…çš„æ—©æœŸå¹²é¢„ç‡ï¼Œé™ä½ç»“ç›´è‚ ç™Œçš„å‘ç—…ç‡ã€‚æœªæ¥ï¼Œè¯¥æ¨¡å‹æœ‰æœ›æ‰©å±•åˆ°å…¶ä»–ç±»å‹çš„åŒ»ç–—å½±åƒåˆ†æä¸­ã€‚

## ğŸ“„ æ‘˜è¦ï¼ˆåŸæ–‡ï¼‰

> Identification of precancerous polyps during routine colonoscopy screenings is vital for their excision, lowering the risk of developing colorectal cancer. Advanced deep learning algorithms enable precise adenoma classification and stratification, improving risk assessment accuracy and enabling personalized surveillance protocols that optimize patient outcomes. Ultralight Med-Vision Mamba, a state-space based model (SSM), has excelled in modeling long- and short-range dependencies and image generalization, critical factors for analyzing whole slide images. Furthermore, Ultralight Med-Vision Mamba's efficient architecture offers advantages in both computational speed and scalability, making it a promising tool for real-time clinical deployment.

